Patents by Inventor David Andrew Martin

David Andrew Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
    Publication number: 20240132499
    Abstract: The disclosure relates to USP30 Inhibitor Compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and medical uses involving same.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 25, 2024
    Inventors: Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Matthew W. Martin, Steven Mischke, David James Richard, Angela V. West
  • METHOD OF TREATING DISEASES USING AN IL-17 RECEPTOR ANTIBODY FORMULATION
    Publication number: 20230192873
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Application
    Filed: October 11, 2022
    Publication date: June 22, 2023
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher Endres
  • Method of treating diseases using an IL-17 receptor antibody formulation
    Patent number: 11505612
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Grant
    Filed: September 8, 2020
    Date of Patent: November 22, 2022
    Assignee: AMGEN K-A, INC.
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher Endres
  • METHOD OF TREATING DISEASES USING AN IL-17 RECEPTOR ANTIBODY FORMULATION
    Publication number: 20200399384
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Application
    Filed: September 8, 2020
    Publication date: December 24, 2020
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher Endres
  • IL-17 receptor antibody formulation
    Patent number: 10808033
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: October 20, 2020
    Assignee: Amgen K-A, Inc.
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher Endres
  • METHOD OF TREATING PSORIASIS USING AN IL-17 RECEPTOR ANTIBODY FORMULATION
    Publication number: 20180346583
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Application
    Filed: August 2, 2018
    Publication date: December 6, 2018
    Inventors: Dingjiang Liu, Holly Zhouhong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walker Baumgartner, Christopher Endres
  • Method of treating psoriasis using an IL-17 receptor antibody formulation
    Patent number: 10072085
    Abstract: The present disclosure relates to ?M-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: September 11, 2018
    Assignee: Kirin-Amgen, Inc.
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher Endres
  • IL-17 Receptor Antibody Formulation
    Publication number: 20150017184
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 15, 2015
    Applicant: KIRIN-AMGEN, INC.
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher Engres
  • IL-17 receptor antibody formulation
    Patent number: 8883151
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Grant
    Filed: January 12, 2011
    Date of Patent: November 11, 2014
    Assignee: Kirin-Amgen, Inc.
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher J. Endres
  • ANTIBODY FORMULATION AND THERAPEUTIC REGIMENS
    Publication number: 20130022621
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Application
    Filed: January 12, 2011
    Publication date: January 24, 2013
    Applicant: AMGEN INC
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher J. Endres
  • USE OF IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
    Publication number: 20120308566
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for treating diseases, such as various forms of cancer.
    Type: Application
    Filed: October 12, 2010
    Publication date: December 6, 2012
    Inventors: David Andrew Martin, Joel Tocker, Scott Baumgartner, Donna Christine Franko
  • CMOS imager with an A/D per pixel convertor
    Patent number: 6271785
    Abstract: An image sensor (10) which can be fabricated using conventional CMOS processes uses a comparator circuit (18) at each pixel (14) having a first input coupled to a photodetector (16) and a second input coupled to a ramp signal generator (30, 32). The ramp signal generator (30, 32) is comprised of a counter (32) and a D/A conversion circuit (30) with the analog output of the D/A conversion circuit (30) forming an analog ramp input to the comparator circuit (18). A counter circuit (32) can be used to drive the digital side of the D/A conversion circuit (30) and configured to count from 0 to 2n−1 to 0, N being the resolution of the photodetector (16). The output of the D/A conversion circuit (30) causes comparator circuit (18) to flip when the ramp signal is equal to the value of the output from the photodetector (16). The comparator circuit (18), in turn, drives a load signal to a register (38) which stores the counter values 32 from pixel (14) at the instant the comparator 18 flips.
    Type: Grant
    Filed: April 15, 1999
    Date of Patent: August 7, 2001
    Assignee: Texas Instruments Incorporated
    Inventors: David Andrew Martin, Krishnaswamy Nagaraj